PA143043
Factor VII Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PA143043-Each-of-1 | In Stock | ₹ 29,325.50 |
PA143043 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 29,325.50
GST (18%): ₹ 5,278.59
Total Price: ₹ 34,604.09
Antigen
Factor VII
Classification
Polyclonal
Conjugate
Unconjugated
Gene
F7
Gene Alias
AI132620; Cf7; Coagulation factor VII; coagulation factor VII (serum prothrombin conversion accelerator); eptacog alfa; F7; Factor 7; Factor VII heavy chain; Factor VII light chain; Factor7; FVII; FVII coagulation protein; proconvertin; Serum prothrombin conversion accelerator; SPCA
Host Species
Sheep
Purification Method
purified
Regulatory Status
RUO
Gene ID (Entrez)
2155
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
ELISA, Western Blot
Concentration
9.1 mg/mL
Formulation
50% water with 50% glycerol and no preservative
Gene Accession No.
P08709
Gene Symbols
F7
Immunogen
Human factor VII.
Quantity
1 mg
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- PA1-43043 detects Factor VII in human samples
- PA1-43043 has successfully been used in Western blot and ELISA applications
- PA1-43043 was derived from human factor VII
- Coagulation factor VII is a vitamin K-dependent factor essential for hemostasis
- This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis
- Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond
- In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa
- Defects in F7 production can cause coagulopathy.